RBC Capital analyst Gregory Renza maintained a Hold rating on Fulcrum Therapeutics (FULC – Research Report) yesterday and set a price ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

Fintel reports that on November 13, 2024, RBC Capital initiated coverage of Jumia Technologies AG - Depositary Receipt () (NYSE:JMIA) with a Sector Perform recommendation. Analyst Price Forecast ...

(Nasdaq: IDCC) announced its participation in the upcoming 2024 RBC Capital Markets Technology, Internet, Media & ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

RBC Capital keeps an Outperform rating and $14 price target on Coty after its Q1 like-for-like sale sales growth cut. Unexpected tighter retailer inventory management likely drove downside in the ...

The top 10 underwriters for healthcare issuance accounted for a total of $16.65 billion. RBC Capital Markets ranked No. 1 ...

RBC Capital analyst Deane Dray raised the firm’s price target on Wesco (WCC) to $199 from $186 and keeps a Sector Perform rating on the shares after its Q3 earnings beat. The company’s end ...

RBC Capital raised the firm’s price target on ResMed (RMD) to $232 from $224 and keeps a Sector Perform rating on the shares. The company reported a strong Q1 result with double digit revenue ...

RBC Capital Markets has downgraded Mobileye from Outperform to Sector Perform and slashed its price target from $24 to $11.Market Domination Hosts Julie Hyman and Josh Lipton report more on the ...

TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including IBM and Ares Capital.

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...